Table 2.
Comparison of bone health at study entry in early COC users and other COC users
Variables at study entry | Early COC use n = 8 | COC use n = 26 | P |
---|---|---|---|
| |||
Age (years)a | 19.5 ± 0.7 | 19.2 ± 0.5 | 0.173 |
Body mass index (kg/m2)a | 24.2 ± 3.8 | 23.2 ± 2.7 | 0.434 |
Years after menarche began COCa Bone sitesb (g/cm2) | 2.9 ± 0.9 | 5.5 ± 1.0 | < 0.001 |
Anterior–posterior spine | 0.972 ± 0.029 | 1.020 ± 0.016 | 0.151 |
Lateral spine | 0.745 ± 0.024 | 0.790 ± 0.013 | 0.105 |
Femoral neck | 0.835 ± 0.038 | 0.925 ± 0.021 | 0.048 |
Total hip | 0.934 ± 0.030 | 1.009 ± 0.017 | 0.035 |
Whole body | 1.007 ± 0.020 | 1.053 ± 0.011 | 0.050 |
P value for MANCOVA controlling for lean body mass at study entry, with Bonferroni correction
COC combined oral contraceptives, Early COC User women who began using COC medication ≤ 4 years menarche, COC Use women who began using COCs > 4 years after menarche
Means with standard deviations
Adjusted means with standard error